Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.


TSX:PRN - Post by User

Bullboard Posts
Comment by VerusSemperSorson Mar 26, 2018 9:37am
100 Views
Post# 27780332

RE:Be careful

RE:Be careful
AlgAlg wrote: Am saying, as above...it went up and down and up and seems going down.
When one sees comments in a news releases like ‘if and when’, those shud be a cautionary statement.  
BHP is non cancerous!
Lets be honest with people..$6.61?   Hummmmmmmmmm doubtful.
GUD is likely not wrong but they did lose nearly $1million several years ago...on a Company.
And GUD ‘extended’, yes extended a loan for $4million approx 2+ years ago.
GUD is not in this loan!
Food for thot!




The author of the article mentioning $6.61 has a target of $3 (up from $2.25, I think). The $6.61 was based on a number of IFs playing out in a positive  way. It's worth contemplating that upside potential, but the target was $3. The author was not suggesting that $6.61 was anything but doubtful, given the IFs mentioned. Was this bullish article was out of line?  

Bullboard Posts